Novartis to invest $23 billion on expansion of manufacturing and R&D facilities in US
Expanded US manufacturing and R&D presence with investment in 10 facilities, including 7 brand new facilities
Expanded US manufacturing and R&D presence with investment in 10 facilities, including 7 brand new facilities
L-HPC was independently developed by Shin-Etsu Chemical as a disintegrant for tablets
ALPLA is going to manufacture high-quality plastic bottles, preforms, matching closures and injection-molded parts in Chachoengsao using all core technologies
The facility is equipped with state-of-the-art technology to produce high-quality lyophilized (freeze-dried) products
Construction of the plant will commence in 2025 with first production expected to be in 2027
This initiative aims to raise awareness about the importance of monitoring blood sugar levels before indulging in sweets
He will lead the final stages of work to commission the 54,000-square-foot facility and then lead ongoing operations at the site
SMS Pharmaceuticals has reported total income of Rs. 165.81 crores during the quarter ended June 30, 2024
Rusan’s API facility in Ankleshwar is GMP approved by other stringent international agencies as well
Subscribe To Our Newsletter & Stay Updated